Announcing Earth Day Plus (Apr 22 to May 3) – VC-Founder Matchup + Live Sessions. Learn More

Nov 10, 2023

Introducing IndieBio SF’s new office at 3rd St. in San Francisco’s Dogpatch

As you ride the elevator to the third floor of the American Industrial Center (AIC) at 3rd Street in San Francisco’s Dogpatch neighborhood, the smell of sweetly spiced bread permeates the otherwise industrial air. Once filled with warehousing and manufacturing companies, the sprawling AIC—often referred to as a skyscraper on its side—is now home to […]

Recent news

Post Apr 02, 2024

Announcing SOSV’s VC-Founder Climate Tech Matchup April 22-May 3

Announcing the 2024 Climate Tech VC-Founder Matchup, with meetings taking place online between April 22nd (Monday – Earth Day!) and May 3rd (Friday). This virtual event will bring together 1,000 startups and 1,000 investors for 1:1 meetings online over two weeks, scheduled at mutually convenient times, making it one of the largest such events worldwide […]

TechCrunch Apr 16, 2024

SOSV Closes $306M Deep Tech Fund for Human and Planetary Health

SOSV announced the close of its $306 million SOSV V fund, the firm’s largest fund to date. The news received coverage in TechCrunch, Bloomberg and Axios. The text below is from the press release SOSV issued on April 16th concerning the new fund. SOSV V will focus on deep tech startups in human and planetary health, […]

Post Mar 27, 2024

Announcing HAX’s May 1st Demo Day

Investors! Join HAX in Newark on May 1st for Demo Day featuring 20+ startups across climate, industry, and health.

Deep Tech Meetup Boston
Mar 14, 2024

Catch HAX’s Duncan Turner and Susan Schofer in Boston April 24 & 25

As the buildout of HAX’s new 35,000 square foot facility in Newark, NJ nears its official opening this spring,the HAX team is hitting the road to get the word out and meet prospective founders for the HAX startup development program. Boston is top of the list, on April 24 & 25, for two events: a […]

Human Health 100 2024 thumbnail
Post Mar 11, 2024

Announcing the 2024 Human Health 100

Welcome to the third annual SOSV Human Health 100. The list features SOSV’s 100 most exciting companies in the health category, which for SOSV ranges very widely, from assistive robotics and remote care to therapeutics and diagnostics.  In the past two years (see the 2023 and 2022 lists), venture rounds and company valuations grew strongly, […]

Post Feb 02, 2024

2024: Deep Tech in the Spotlight

SOSV Founder and Managing General Partner Sean O’Sullivan delivers a 2024 message focused on deep tech investing.

News Medical Jan 22, 2024

RizLab’s CytoTracker provides highly accurate white blood cell count with single drop of blood

RizLab (IndieBio NY & HAX) has developed an ultra-compact, all-electronic cytometer capable of quantifying white blood cells and the key subtypes with just a prick of the finger—with 97% accuracy, as validated by the recent clinical trial results published in PLOS One. RizLab’s CytoTracker can quantify important WBC parameters such as the total white blood […]

Post Sep 22, 2023

UPSIDE Foods announces first commercial-scale plant; debuts “Road to Rubicon” series

UPSIDE Foods has had no shortage of incredible milestones lately: following landmark regulatory approvals by the FDA & USDA, the company recently partnered with San Francisco’s Bar Crenn to make its cultivated chicken commercially available (snag a coveted reservation to try it if you can!), and last week announced its first commercial-scale plant, dubbed Rubicon, […]

TechCrunch Sep 21, 2023

Watch the 3 SOSV founder pitches that landed in the Top 20 at TechCrunch Disrupt Battlefield 2023

Congratulations to the three SOSV portfolio companies that made the Top 20 at TechCrunch Disrupt Battlefield 2023! Take a look at the amazing innovations in human & planetary health they’re currently working on: 🌾 Brendan Collins and the team at Avalo (IndieBio) are betting the company’s AI can speed up the creation of climate-resistant crops—a crucial technology amid increasingly extreme weather […]

Post Jul 20, 2023

Ten63 Founder on Using Generative AI To “Drug the Undruggable”

At SOSV’s annual general meeting last month, Po Bronson sat down with CEO Marcel Frenkel, PhD, of Ten63 Therapeutics (IndieBio 2019) to discuss the company’s latest milestones and work with AI. Frenkel shared how Ten63’s BEYOND platform “combines physics and AI in hyper-efficient search algorithms” to push the boundaries of computational drug discovery. In short, […]

Post Jul 20, 2023

Check out IndieBio’s two latest cohorts: SF14 & NY6

In a challenging funding climate with total deal flow and valuation down, IndieBio has continued to invest aggressively in deep tech that is paving the way for a healthier future—both for humanity and the planet. As a result of this strategy, we’re excited to announce that both of SOSV’s IndieBio programs debuted their latest cohorts. […]